Gerhard Bauer
Directeur/Membre du Conseil chez Sitem-Insel AG
Profil
Gerhard Bauer is currently a Director at Sitem-Insel AG and Swiss Medtech.
Previously, he worked as the VP-Global Operations & Engineering Officer at Bausch & Lomb, Inc. He also worked as a Portfolio Manager at Raiffeisen Kapitalanlage-Gesellschaft mbH from 2002 to 2006.
From 2010 to 2020, he was the Head-Research, Development & Operations at Straumann Holding AG.
He also worked as a Principal at GlaxoSmithKline, Inc. Dr. Bauer holds a graduate and doctorate degree from Ludwig-Maximilians-Universität München.
Postes actifs de Gerhard Bauer
| Sociétés | Poste | Début |
|---|---|---|
| Sitem-Insel AG | Directeur/Membre du Conseil | - |
| Swiss Medtech | Directeur/Membre du Conseil | - |
Anciens postes connus de Gerhard Bauer
| Sociétés | Poste | Fin |
|---|---|---|
| STRAUMANN HOLDING AG | Directeur des opérations | 01/05/2020 |
Raiffeisen Kapitalanlage-Gesellschaft mbH
 Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen Kapitalanlage-Gesellschaft mbH (RKG) is the wholly-owned fund management subsidiary of Raiffeisen Bank International AG (VSE: RBI; ADR: RAIFY) in Austria. Founded in 1985, the firm is headquartered in Vienna and manages the Raiffeisenfonds fund range for institutional and individual investors. | Gestionnaire de Portefeuille-Actions | 26/09/2006 |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Directeur des opérations | - |
Formation de Gerhard Bauer
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STRAUMANN HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Raiffeisen Kapitalanlage-Gesellschaft mbH
Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen Kapitalanlage-Gesellschaft mbH (RKG) is the wholly-owned fund management subsidiary of Raiffeisen Bank International AG (VSE: RBI; ADR: RAIFY) in Austria. Founded in 1985, the firm is headquartered in Vienna and manages the Raiffeisenfonds fund range for institutional and individual investors. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
| Sitem-Insel AG | |
| Swiss Medtech |
